|
COPYRIGHT 2004 International Medical News Group
NEW ORLEANS -- The addition of a dopamine agonist to somatostatin analogue therapy appears to help control acromegaly, regardless of initial prolactin levels, Dinesh Selvarajah, M.D., said in a poster session at the annual meeting of the Endocrine Society.
Findings from a study of nine patients with acromegaly suggest...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
